간암 진단 시장 조사 – 규모, 점유율, 개발 및 미래 범위 2031

  • Report Code : TIPRE00003017
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 181
Buy Now

간암 진단 시장은 2021년 93억 2,314만 달러에서 2028년 159억 5,177만 달러에 이를 것으로 예상되며, 2021년부터 2028년까지 연평균 8.0% 성장할 것으로 예상됩니다.



간암은 간세포에서 시작됩니다. 여러 종류의 암이 간에서 형성될 수 있습니다. 간세포 암종은 가장 흔한 간암으로 간주되며 간세포에서 시작됩니다. 미국임상종양학회(ASCO)에 따르면 성인 원발성 간암의 약 80%가 간세포암종이다. 다른 유형의 간암에는 간모세포종 및 간내 담관암이 포함됩니다. 이들은 덜 일반적인 것으로 간주됩니다. 간암 진단은 간암 식별 및 확인에 사용되는 기술로 구성됩니다.



전략적 통찰력



간암 진단 시장 성장의 원인은 다음과 같습니다. 간암의 유병률 증가 및 새로운 진단 테스트 개발에 대한 R&D 투자 증가. 반면, 기술적으로 진보된 간암 진단 솔루션의 높은 비용은 시장의 성장을 방해합니다.



간암 진단 시장의 유리한 지역


< TIP>

시장 통찰력 새로운 진단 테스트 개발에 R&D 투자 증가



간암 진행을 정확하게 진단하는 능력은 적절한 치료 옵션을 선택하는 데 중요합니다. 또한, 다양한 기업과 조직은 증가하는 수요에 대응하여 이 질병의 조기 식별을 위한 혁신적인 솔루션을 개발하고 구현하기 위해 엄청난 노력을 기울였습니다. 예를 들어, 2020년 3월 Roche Holding AG의 Elecsys GALAD 점수는 진행성 간암의 조기 발견을 위한 미국 식품의약국의 획기적인 장치 상태를 받았습니다. 스위스 제약회사의 계산기는 연령, 성별, 바이오마커 결과 등의 요소를 결합하여 간암의 가장 흔한 형태인 초기 간세포 암종을 감지합니다. 또한 Elecsys GALAD 점수는 임상의에게 간세포 암종을 적시에 정확하게 진단하여 지원하도록 설계되었습니다. 연구개발(R&D) 지출은 2021년 146억5000만달러, 2020년 131억7000만달러였다. F. Hoffmann-La Roche Ltd의 R&D 지출은 핵심 기준으로 14% 증가했으며, 대부분 종양학, 안과 및 맞춤형 의료 분야에 대한 후기 단계 투자에 힘입었습니다. 2021년 진단 사업부의 R&D 투자액은 18억 7,892만 달러였다. 마찬가지로 2019년 11월 EXACT Sciences Corporation은 간암 조기 발견을 위한 혈액 기반 테스트에 대해 식품의약국(FDA)의 획기적인 지정을 받았습니다. 또한 2020년 6월 국립보건원(NIH) 과학자들은 국립암연구소(NCI) 연구원들이 이끄는 간암 검진 개선에 도움이 되는 혈액 검사를 개발했습니다. 또한 2019년 6월에는 액체 생검 검사인 CancerSEEK가 Johns Hopkins University의 연구원들에 의해 설계되었습니다. 이 검사는 위암, 간암, 난소암, 식도암 등 여러 암을 조기에 진단해 조기 치료가 용이하도록 설계됐다. 따라서 R&D 투자 증가와 간암 진단을 위한 진단 테스트 개발이 간암 진단 시장을 주도하고 있습니다.



유형 기반 통찰력


< TIP>

세계 간암 진단 시장은 종류에 따라 실험실 검사, 내시경 검사, 영상 검사, 생검 등으로 구분된다. 실험실 테스트 부문 시장은 혈액 테스트와 바이오마커로 세분화됩니다. 실험실 테스트 부문은 2021년에 시장에서 가장 큰 점유율을 차지했습니다. 그러나 이미징 부문은 예측 기간 동안 시장에서 8.5%의 CAGR을 등록할 것으로 예상됩니다.



간암 진단 시장 유형별 – 2021년 및 2028년



최종 사용자 기반 통찰력


< TIP>

글로벌 간암 진단 시장은 최종 사용자를 기준으로 병원 및 진단 연구소, 학술 및 연구 기관, CRO 연구소로 구분됩니다. 병원 및 진단 실험실 부문은 병원이 전문 과학 장비를 통해 의료 시설을 제공하기 때문에 2021년에 시장에서 가장 큰 점유율을 차지했습니다. 훈련된 직원 팀이 병원의 현대 의학과 관련된 문제를 처리, 조사 및 복원하도록 지정됩니다. 다양한 의학 연구팀은 진단 방법 및 기타 의료 분야 활동과 관련된 혁신적인 기술을 도입하기 위해 끊임없이 노력하고 있습니다. 환자들은 일반적으로 고급 치료 옵션이 있기 때문에 병원에서 간암 치료를 받는 것을 선호합니다. 병원은 환자를 돌보는 곳입니다. 또한, 동일한 세그먼트는 예측 기간 동안 시장에서 8.5%의 CAGR을 기록할 것으로 예상됩니다.



제품 출시 및 승인은 기업이 글로벌 입지를 확장하기 위해 일반적으로 채택하는 전략입니다. 간암 진단 시장 점유율을 지배하기 위한 제품 포트폴리오. 또한 시장 참여자는 고객을 확대하기 위한 파트너십 전략에 중점을 두어 브랜드 이름을 전 세계적으로 유지할 수 있습니다. 간암 진단 시장 점유율은 시장 참가자의 새로운 혁신 제품 개발로 번성할 것으로 예상됩니다.



회사 프로필



    < TIP>
  1. Abbott

  2. BioMerieux SA

  3. F. HOFFMANN-LA ROCHE LTD

  4. Illumina, Inc.

  5. Koninklijke Philips NV

  6. QIAGEN

  7. Siemens Healthineers AG

  8. THERMO FISHER SCIENTIFIC INC.

  9. GE Healthcare

  10. Perspectum
  11. Helio, Inc.



Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are liver cancer diagnostics?

The abnormal proliferation of cells in the body is referred to as cancer. Cancer of the liver starts in the cells of the liver. The liver can develop a variety of cancers. Hepatocellular carcinoma is the most prevalent type of liver cancer, and it starts in the hepatocyte. Some liver cancers can be detected through screening in persons who are at high risk but do not have symptoms, but most liver cancers are discovered when they produce symptoms. To detect liver disease, a series of blood tests known as liver function tests and imaging studies are employed.

What are the driving factors for the liver cancer diagnostics market across the globe?

Key factors that are driving the growth of this market are the rising prevalence of liver cancer and rising R&D investments for the development of novel diagnostic testing are expected to boost the market growth for liver cancer diagnostics over the years.

What is the market CAGR value of the liver cancer diagnostics market during the forecast period?

The CAGR value of the liver cancer diagnostics market during the forecasted period of 2021-2028 is 8.0%.

Which type led the liver cancer diagnostics market?

The laboratory tests segment held the largest share of the market in the global liver cancer diagnostics market and held the largest market share of 39.61% in 2021.

Which end user held the largest share in the liver cancer diagnostics market?

The hospitals and diagnostic laboratories segment dominated the global liver cancer diagnostics market and accounted for the largest market share of 48.56% in 2021.

Who are the key players in the Liver Cancer Diagnostics market?

The liver cancer diagnostics market majorly consists of players such as Abbott; bioMerieux SA; F. HOFFMANN-LA ROCHE LTD.; Illumina, Inc.; Koninklijke Philips N.V.; QIAGEN; Siemens Healthineers AG; THERMO FISHER SCIENTIFIC INC.; GE Healthcare; Perspectum; Helio, Inc amongst others.

Which are the top companies that hold the market share in liver cancer diagnostics market?

Koninklijke Philips N.V. and Siemens Healthineers AG are the top two companies that hold huge market shares in the liver cancer diagnostics market.

Which region is expected to witness significant demand for the liver cancer diagnostics market in the coming years?

The North America region secures a substantial share of the global liver cancer diagnostics market. The growth of the market in the region is attributed by the rising prevalence of liver cancer. In North America, the US is the largest market for liver cancer diagnostics. The growth of this market is primarily driven by the growing prevalence of liver cancer diseases, technological advancements and developments in the US are going to accelerate the growth of this market in this country.

What is the COVID 19 impact on the Liver Cancer Diagnostics market in the coming years?

The coronavirus disease 2019 (COVID-19) pandemic has caused unprecedented problems to healthcare systems, and patients with liver cancer (LC) may have been particularly affected. COVID-19 may aggravate pre-existing chronic liver damage in HCC patients, complicating cancer treatment. Cancer patients, especially those who have just completed treatment, are at a higher risk of infection and have a poorer prognosis. The first wave of the COVID-19 epidemic had a huge influence on liver cancer patients' normal care. Patients' outcomes may have been considerably harmed as a result of changes to screening, diagnostic, and treatment algorithms. The benefits and drawbacks of the tactics used will be reported through ongoing data collecting and future analysis, assisting future decision-making. However, in the long run, as the vaccination schedule is established and the transmission rate decreases, healthcare systems will return to normal and is expected to experience increased demand for liver cancer diagnostics.

The List of Companies - Liver Cancer Diagnostic Market

  1. Abbott
  2. BioMerieux SA
  3. F. HOFFMANN-LA ROCHE LTD
  4. Illumina, Inc.
  5. Koninklijke Philips N.V
  6. QIAGEN
  7. Siemens Healthineers AG
  8. THERMO FISHER SCIENTIFIC INC.
  9. GE Healthcare
  10. Perspectum
  11. Helio, Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports